Pharmaceutical company to pay $1 million to settle claims on switching drugs

Share this article:

The Maine subsidiary of Omnicare Pharmacy, a Fortune 500 company, agreed to pay $1 million to settle claims that it switched nursing home patients' prescriptions to a medication that would be more profitable for the company.

Omnicare provides medication for about 7,000 nursing home patients in Maine. The company is accused of creating fake prescriptions to switch patients' heartburn medicine, which meant that the state's Medicaid program paid $82 per month per patient instead of $15.

Patients were switched from tablet form of ranitidine, a generic heartburn medication, to the capsule form. Experts say the two different forms are not therapeutically equivalent.

The company denies the claims but said it settled the charges to avoid extraneous litigation costs.

Share this article:

More in News

'Minor' issues at the nursing home can cause disastrous care transitions, expert warns

'Minor' issues at the nursing home can cause ...

What may appear to be minor administrative problems in a nursing home - a fax machine locked away at night or no one designated to copy paperwork - can cause ...

Long-term care facilities approach 80% worker flu vaccination rate after handing power ...

Fourteen long-term care facilities in Pennsylvania dramatically increased their staff flu vaccination rate by having a regional pharmacy take over the process, according to a report issued Thursday by the Agency for Healthcare Quality and Research (AHQR).

RACs were 'most improved' healthcare auditors for getting back money in 2013, ...

Medicare Recovery Audit Contractors dramatically stepped up their overpayment recoveries last year, returning nearly $487 million more to the government than they did in 2012, according to a new report from a federal watchdog agency.